Ron Grace serves as general corporate and transactional counsel, advising businesses on a broad range of transactions. He works with both emerging and established companies on mergers and acquisitions, joint ventures, strategic partnerships, private placements of equity securities and general contract, securities and health care matters.

In health care, Ron represents clients across the United States with an emphasis on health care industry providers, including ambulatory surgical centers (ASCs), surgical hospitals and physician practices. He leads teams through all phases of health care transactions for both buyers and sellers, from due diligence to closing and beyond, with a focus on the middle-market. Ron has extensive knowledge of health care laws, including the Stark Law and the federal Anti-Kickback Statute and regularly advises clients on compliance issues.

In his general corporate practice, Ron helps businesses manage day-to-day operations, providing guidance on risk management, deal structuring and the review, drafting and negotiation of commercial contracts. He also represents clients in raising capital through private securities offerings under Regulation D of the Securities Act of 1933 and applicable state laws.

Ron advises emerging businesses on company formation and governance, including choice of entity and the preparation of partnership agreements, operating agreements, shareholder agreements and other formation documents.

Education

  • Loyola Law School, Los Angeles (J.D., 1995)
    • St. Thomas More Honor Society, Member
  • University of California, Santa Barbara (B.A., with honors, 1991)

    Bar Admission

    • California, 1995

    Recognition

    • Ranked in Chambers USA Guide: America’s Leading Lawyers for Business, California, Healthcare, 2021-2025

    Community

    • Association for Corporate Growth – Los Angeles Chapter, Member
    • ProVisors Professional Networking Group – Century City 7 Chapter, Member
    Publications
    Governor Newsom Embraces Tighter Requirements on Private Equity and Hedge Fund Investments in California Health Care By Signing AB 1415 and SB 351
    This month, Governor Newsom signed AB 1415 and SB 351 into law, two bills that will enhance the requirements on investments by private equity groups and hedge funds in California health care. As detailed below, AB 1415 will significantly expand the reach of the Office of Health Care Affordability (OHCA), and SB 351 further codifies restrictions on the role that private equity groups and hedge funds can play in the management of medical and dental practices. Both bills will go into effect on January 1, 2026. Collectively, these measures add to the burdens and scrutiny faced by private equity and hedge funds that invest in the health care sector, although other health care stakeholders may feel the ripple effects as well.  Many
    Read More
    California Bills Expanding OHCA Requirements, Impacting Private Equity Investment in Health Care and MSOs Heads to Governor Newsom’s Desk
    Key Takeaways More Transactions Under Review: AB 1415 would require notice to OHCA for a wider range of health care deals involving private equity, hedge funds, and MSOs. Limits on Investor Control: SB 351 reinforces restrictions preventing non-physician investors from influencing medical and dental decision-making. Plan Ahead for 2026 Deals: Parties should assess now whether upcoming transactions may trigger new notice obligations and affect closing timelines. Compliance Check: California health care operators and investors should review agreements and structures for alignment with CPOM requirements. Last week the California legislature passed AB 1415 and SB 351, sending both bills to Governor Newsom for review. If signed into law, both bills would increase regulatory scrutiny on private equity groups and hedge funds investing in the California health
    Read More